COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 1125: Articles 11241-11250  | Next

Determining international spread of novel B.1.1.523 SARS-CoV-2 lineage
Zemaitis, L., Alzbutas, G., Gecys, D., Komissarov, A., Pautienius, A., Ugenskiene, R., Sukys, M., Lesauskaite, V.
10.1101/2021.11.21.21266655 — Posted: 2021-11-24
Establishing and characterising large COVID-19 cohorts after mapping the Information System for Research in Primary Care in Catalonia to the OMOP Common Data Model
Burn, E., Fernandez-Bertolin, S., Voss, E. A., Blacketer, C., Aragon, M., Recalde, M., Roel, E., Pistillo, A., Raventos, B., Reyes, C., van Sandijk, S., Halvorsen, L., Rijnbeek, P. R., Duarte-Salles, T.
10.1101/2021.11.23.21266734 — Posted: 2021-11-24
Impacts of vaccination and asymptomatic testing on SARS-CoV-2 transmission dynamics in a university setting
Nixon, E. J., Thomas, A. C., Stocks, D. A., Barreaux, A. M. G., Hemani, G., Trickey, A., Kwiatkowska, R., Walker, J. G., Ellis, D., Danon, L., Relton, C., Christensen, H., Brooks Pollock, E.
10.1101/2021.11.22.21266565 — Posted: 2021-11-24
Factors associated with COVID-19 vaccine acceptance and hesitancy among residents of Northern California jails
Liu, Y. E., Oto, J., Will, J., LeBoa, C., Doyle, A., Rens, N., Aggarwal, S., Kalish, I., Rodriguez, M., Sherif, B., Trinidad, C., del Rosario, M., Allen, S., Spencer, R., Morales, C., Chyorny, A., Andrews, J. R.
10.1101/2021.11.22.21266559 — Posted: 2021-11-24
Development and Performance verification of colloidal gold labeled SARS-CoV-2 antigen detection method for routine popular screening of COVID-19 with clinical samples in Poland and China
Guo, C., Yao, L., Chen, F., Zhang, C., Chen, W.
10.1101/2021.11.22.21266719 — Posted: 2021-11-24
The Failures of an Ideal COVID-19 Vaccine: A Simulation Study
Kosinski, R. J.
10.1101/2021.11.22.21266669 — Posted: 2021-11-24
Final sizes and durations of new COVID-19 pandemic waves in Ukraine and around the world predicted by generalized SIR model
Nesteruk, I.
10.1101/2021.11.22.21266683 — Posted: 2021-11-24
Simulating the impact of vaccination rates on the initial stages of a COVID-19 outbreak in New Zealand (Aotearoa) with a stochastic model
Watson, L. M.
10.1101/2021.11.22.21266721 — Posted: 2021-11-24 Discussion: Onsite
In vitro, classical complement activation differs by disease severity and between SARS-CoV-2 antigens
Lamerton, R. E., Marcial Juarez, E., Faustini, S. E., Perez-Toledo, M. E., Goodall, M., Jossi, S. E., Newby, M. L., Chapple, I., Dietrich, T., Veenith, T., Shields, A. M., Harper, L., Henderson, I. R., Rayes, J., Wraith, D. C., Watson, S. P., Crispin, M., Drayson, M. T., Richter, A. G., Cunningham, A. F.
10.1101/2021.11.22.21266681 — Posted: 2021-11-24
The role of multi-generational household clusters in COVID-19 in England
Thelwall, S., Zaidi, A., Nsonwu, O., Rice, W., Chudasama, D., Lamagni, T., Dabrera, G.
10.1101/2021.11.22.21266540 — Posted: 2021-11-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).